Incyte CEO awarded stock, options and performance shares

INCYTE CORP Chief Executive Officer William Meury received multiple equity awards on July 16, 2026.

Rhea-AI Filing Summary

INCYTE CORP Chief Executive Officer William Meury received multiple equity awards on July 16, 2026. He was granted 26,807 restricted stock units that vest 25% annually over four years, 77,148 stock options with a $116.65 exercise price, and 80,421 performance shares that can deliver up to 200% of one share each based on relative total shareholder return over a three-year period.

Following these awards, his direct common stock exposure totals 183,129 shares, including 178,883 shares issuable from previously reported unvested restricted stock units and earned performance stock units.

Insider Trade Summary

Grant/Award: 184,376 shares

Grant/Award 3 txns

Insider Meury William

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Performance Shares F3	80,421	$0.00	$0.00
Grant/Award	Employee Stock Option (right to buy) F4	77,148	$0.00	$0.00
Grant/Award	Common Stock F1, F2	26,807	$0.00	$0.00

Holdings After Transaction: Performance Shares — 80,421 contracts (Direct); Employee Stock Option (right to buy) — 77,148 contracts (Direct); Common Stock — 183,129 shares (Direct)

Footnotes (4)

1. F1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
2. F2. Including the July 16, 2026 grant, this includes an aggregate of 178,883 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
3. F3. Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
4. F4. The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks:

Key Figures

RSUs granted: 26,807 shares Stock options granted: 77,148 options Option exercise price: $116.65 per share +4 more

7 metrics

RSUs granted 26,807 shares Restricted stock units awarded to CEO William Meury on July 16, 2026

Stock options granted 77,148 options Employee stock options granted to the CEO on July 16, 2026

Option exercise price $116.65 per share Exercise price of the July 16, 2026 CEO stock option grant

Performance shares granted 80,421 units Performance share units awarded to the CEO on July 16, 2026

Max shares per performance unit 200% of one share Each performance share can deliver up to 200% of one share based on TSR

Direct common stock exposure 183,129 shares Total direct common stock holdings after July 16, 2026 awards, including unvested RSUs and earned PSUs

Unvested equity underlying shares 178,883 shares Shares issuable from previously reported RSUs and earned performance stock units that have not vested

Key Terms

restricted stock units ("RSUs"), performance share, relative total shareholder return ("TSR"), fixed peer group, +1 more

5 terms

restricted stock units ("RSUs") financial

"Represents award of restricted stock units ("RSUs") that will vest 25% annually"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

performance share financial

"Each performance share represents the right to receive up to 200% of one share"

A performance share is a grant of company stock given to employees or executives that is earned only if the business meets specified performance goals over a set period, similar to receiving a bonus that pays out in shares instead of cash. For investors, performance shares matter because they reveal how management is being rewarded and motivated, can create future share dilution when paid, and link executive pay directly to results that affect shareholder value.

relative total shareholder return ("TSR") financial

"earned based upon the issuer's relative total shareholder return ("TSR") over a three-year"

fixed peer group financial

"as compared to the TSR of companies in a fixed peer group, as set forth"

Performance Share Award Agreement financial

"as set forth in the Performance Share Award Agreement"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did INCYTE CORP (INCY) CEO William Meury receive on July 16, 2026?

William Meury received 26,807 restricted stock units, 77,148 stock options with a $116.65 exercise price, and 80,421 performance shares. These awards are subject to multi-year vesting and, for performance shares, relative total shareholder return conditions.

How many restricted stock units were granted to INCY CEO William Meury and how do they vest?

He was granted 26,807 restricted stock units (RSUs). These RSUs vest 25% annually over four years and are settled only in Incyte common stock on a one-for-one basis, aligning the CEO’s compensation with company share performance over time.

What are the terms of William Meury’s new INCY stock options?

He received 77,148 employee stock options with a $116.65 exercise price, expiring on July 15, 2036. The options vest in 37 installments: 25% after one year, with the remaining 75% vesting monthly over the following three years.

How do the performance shares granted to the INCY CEO work?

William Meury was granted 80,421 performance shares, each representing the right to receive up to 200% of one share. Payout depends on Incyte’s relative total shareholder return over a three-year period beginning January 1, 2026, with earned shares vesting on the third anniversary.

What is William Meury’s direct common stock exposure at INCY after these grants?

After the July 16, 2026 awards, his direct common stock exposure totals 183,129 shares. This includes 178,883 shares issuable from previously reported unvested restricted stock units and earned performance stock units, reflecting a significant equity-based component in his compensation.

Were William Meury’s INCY equity grants made under a Rule 10b5-1 trading plan?

The Rule 10b5-1 checkbox for this report is not marked as affirmative, and the footnotes do not reference any Rule 10b5-1 trading plan. The awards are described as equity grants, not trades executed under a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/20/2026 - 04:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Meury William

(Last) (First) (Middle)

1801 AUGUSTINE CUT-OFF

(Street)

WILMINGTON DELAWARE 19803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/16/2026		A		26,807(1)	A	$0	183,129(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Shares	(3)	07/16/2026		A		80,421		(3)	07/16/2029	Common Stock	80,421	$0	80,421	D
Employee Stock Option (right to buy)	$116.65	07/16/2026		A		77,148		(4)	07/15/2036	Common Stock	77,148	$0	77,148	D

Explanation of Responses:

1. Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.

2. Including the July 16, 2026 grant, this includes an aggregate of 178,883 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

3. Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2026 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.

4. The July 16, 2026 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Remarks:

Remarks:

	/s/ Elizabeth Feeney, Attorney-In-Fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)